CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/05/2023
Voltar para busca
Dado oficial do USPTO
MEDICAGO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
04/05/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35, 40, 42
Data de depósito
03/08/2018
Data de registro
26/10/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/10/2021
Última transação
04/05/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
5
Tipo de titular
03
Localização do titular
Québec (Québec), CA
Examinador
MESSICK, TABITHA
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "MEDICAGO" all in blue letters.
Titulares e representantes
Titulares
Medicago Inc.
Representantes
Michelle P. Ciotola CANTOR COLBURN LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and medicinal preparations and substanceshuman vaccinestherapeutic proteins and antibodies for the treatment of infectious diseaseschronic diseases and cancer
Classe 35
Wholesale store services featuring pharmaceuticalspharmaceutical ingredientsvaccinestherapeutic proteins and antibodiesexcluding healthcare plans and healthcare plan management/administration services
Classe 40
Manufacture of pharmaceuticalspharmaceutical ingredientsvaccinestherapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticalspharmaceutical ingredientsvaccinestherapeutic proteins and antibodies
Classe 42
Research and development in the field of vaccinesrecombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccinestherapeutic proteins and antibodies; product research and development and scientific researchall in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticalspharmaceutical ingredientsvaccinestherapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/05/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/05/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/05/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/05/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
26/10/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
21/09/2021
APET
ASSIGNED TO PETITION STAFF
16/09/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/09/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
07/09/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
23/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/03/2021
PUBO
PUBLISHED FOR OPPOSITION
02/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/02/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/01/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
22/01/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
15/09/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
15/09/2020
CNSI
SUSPENSION INQUIRY WRITTEN
15/09/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
15/03/2020
GNSL
LETTER OF SUSPENSION E-MAILED
15/03/2020
CNSL
SUSPENSION LETTER WRITTEN
15/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/03/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
19/09/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
19/09/2019
CNSI
SUSPENSION INQUIRY WRITTEN
19/09/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/09/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/03/2019
GNSL
LETTER OF SUSPENSION E-MAILED
06/03/2019
CNSL
SUSPENSION LETTER WRITTEN
06/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/03/2019
ALIE
ASSIGNED TO LIE
02/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/02/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/09/2018
GNRT
NON-FINAL ACTION E-MAILED
01/09/2018
CNRT
NON-FINAL ACTION WRITTEN
01/09/2018
DOCK
ASSIGNED TO EXAMINER
30/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2018
NWAP
NEW APPLICATION ENTERED
07/08/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MEDICAGO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.